Drug company payments to doctors are a small part of a much larger strategy by Big Pharma to clean our pockets.
If we're going to tackle the skyrocketing cost of prescription drugs, along with so many other issues that are at the top of our community's mind, we need to reform our system and make it work for the people, not special interests and corporations.
Pharmaceutical companies are enjoying unprecedented profits and access with this Administration. Yet the Republicans' prescription drug plan for seniors has been a colossal failure, and over 43 million Americans wake up every morning without health insurance.
It's easy to complain that pharmaceutical companies place profits over people and apparently care more about hair loss than TB. However, many in the pharmaceutical industry would be glad for the opportunity to reorient their research toward medicines that are truly needed, provided only that such research is financially sustainable.
The IP standards advanced countries favour typically are designed not to maximise innovation and scientific progress, but to maximise the profits of big pharmaceutical companies and others able to sway trade negotiations.
If my drug Ragaglitazar had been successful, we would have been getting royalties of thousands of crore rupees every year.
The pharmaceutical industry is spending $1 billion more each year on marketing and lobbying than it does on developing new and better drugs.
You know the pharmaceutical industry. If they are involved with any deal with the government, they are not going to lose any money.
Private companies mostly manufacture medications that resemble what we've already got. They get it patented and, with a hefty dose of marketing, a legion of lawyers, and a strong lobby, can live off the profits for years.
A vigorous and profitable drug industry is not a problem to be solved but a goal to be encouraged.
Whether there is spec buying or not is not the greatest factor in the high cost of pharmaceuticals.
If you look at the world's top 50 drugs being sold today, they are being marketed and sold by companies that did not invent them. I respect patents. I'll pay a royalty. But I shouldn't be denied the right to produce drugs for poor people at reasonable prices.
While I recognize the great value and importance of prescription drugs and strongly support a continued U.S. focus on pharmaceutical research and development, our nation's seniors cannot be asked to subsidize the drug costs of other wealthy industrialized nations any longer.
While American taxes pay for much of the research and development that goes into creating the new, life-saving drugs, American consumers continue to subsidize the cost of the drugs for consumers across the world.
Why is there no cure for cancer? Because the medical industry doesn't want one! And the pharmaceutical industry doesn't want one! Because they would lose too much money!
I don't like protecting pharmaceutical industries and increasing their profits and making our drugs cost more. If the U.S. Democrats could get rid of those problems I'd be much happier.
For a decade, makers of AIDS medicines had rejected the idea of lowering prices in poor countries for fear of eroding profits in rich ones. The position required a balancing act, because the companies had to deflect attacks on the global reach of their patents, which granted exclusive marketing rights for antiretroviral drugs.
It's crucial to keep in mind that the hundreds of millions of dollars now spent on prescription drug advertisements are ultimately paid for by consumers in the form a higher drug prices.
I think Trump's going to make it easier to be a drug company in America.
Blame me for capitalism. Blame me for EpiPen.
Where I come from, Big Pharma's the enemy.
While many have been left behind by Part D, there is a clear winner: the drug industry. Independent analysts predict that Part D will increase drug industry profits by $139 billion over the next eight years. Glaxo-SmithKline's second-quarter net income already jumped 14 percent, and other leading drug companies also have benefited.
It is clear that the pharmaceutical industry is not, by any stretch of the imagination, doing enough to ensure that the poor have access to adequate medical care.
It's wrong to put the drug lobby's interests ahead of older Americans.
The pharma industry is one of the few industries that comes up every year and brags about how much worse they got - like, now it costs $2 billion to make a drug, and it was a billion 5 years ago.
